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Infection of Kaposi’s sarcoma-associated herpesvirus (KSHV) is commonly occurred in AIDS patients.
KSHV and HIV-1 act cooperatively in regulating infection with each other and in human carcinogenesis.
Dendritic cells (DCs), as the pivotal cells in host immunity, may be modulated by both viruses, for
immunoevasion and dissemination, therefore, the interaction between DCs and each virus has been a
prior focus for pathogenesis elucidation. Here, we assessed the potential effect of KSHV on DC–HIV-1
interaction. We found that KSHV stimulation could promote maturation of monocyte-derived
DCs (MDDCs) and impaired the ability of MDDCs to drive proliferation of resting CD4þ T cells,
demonstrating the immunosuppression induced by KSHV. More importantly, KSHV-stimulated MDDCs
could capture more HIV-1 and efﬁciently transferred these infectious viruses to Hut/CCR5 T cell line.
Our results reveal the novel modulation of DC-mediated HIV-1 dissemination by KSHV, and highlight
the importance of studying DC–HIV-1 interaction to elucidate HIV/AIDS pathogenesis.
& 2013 Elsevier Inc. All rights reserved.Introduction
The deterioration of the host immune system caused by HIV-1
infection leads to lack of control of microbial translocation
(Brenchley et al., 2006). As a result, AIDS-associated opportunistic
pathogenic fungi, bacteria and viruses exacerbate deterioration of
the immune response and accelerate AIDS progression (Qin et al.,
2011, 2012). Understanding the immune deterioration induced by
these co-pathogens could facilitate our understanding of HIV/
AIDS pathogenesis.
Kaposi’s sarcoma-associated herpesvirus (KSHV), also known
as human herpesvirus (HHV)-8, is of particular concern when
infecting immunosuppressed individuals, including AIDS patients
(da Silva and de Oliveira, 2011; Lennette et al., 2005). KSHV
infection is associated with multiple human malignancies(Dai
et al., 2012; Sakakibara and Tosato, 2011). In AIDS patients, KSHV
infection commonly causes Kaposi’s sarcoma (KS) (Ahmed et al.,
2012; Armstrong et al., 2013; Restrepo and Ocazionez, 2011). It is
noteworthy that KSHV and HIV-1 co-operate in human carcino-
genesis and viral pathogenesis (Boivin et al., 2000; da Silva and de
Oliveira, 2011), although the co-infection or co-localization of
both viruses seems not critical for their co-operation (Caselli
et al., 2005; Mercader et al., 2001). HIV-1-induced immunell rights reserved.
200025, China.impairment likely contributes to the immunoevasion of herpes-
viruses and signiﬁcantly increases human carcinogenesis. In
contrast, increased HIV-1 replication has been observed in
CD4þ T cells and monocytes when co-cultured with KSHV-
infected cells (Caselli et al., 2005; Mercader et al., 2001).
Dendritic cells (DCs) are pivotal immune cells for regulating host
innate and adaptive immunity. DCs and mononuclear cells may be
targeted by both KSHV and HIV-1 for infection (Rappocciolo et al.,
2006; West et al., 2011), although these two viruses show a big
difference in cellular tropism. Importantly, both viruses can modulate
DC function, and the numerical and functional alterations of DCs
induced by either virus may represent an important strategy for
escaping from the host immune response. KS patients show signiﬁ-
cantly lower frequency of myeloid and plasmacytoid DCs, and this
reduction is greater with advanced stages of disease (Della Bella et al.,
2006). Impairment of DC function by KSHV has been reported in
in vitro studies and in vivo investigations of tumor-bearing animals
and cancer patients with solid or hematological malignancies, and
DCs display signiﬁcant defective antigen uptake and presentation and
allostimulatory ability (Cirone et al., 2012, 2008, 2007; Rappocciolo
et al., 2006; West et al., 2011). KSHV-infected DCs have impaired
production of interleukin (IL)-12 (Della Bella et al., 2006), and skewed
cytokine production towards induction of a T helper (Th)2 response
(Hensler et al., 2009). KSHV also interferes with DC differentiation
from CD34þ andmonocytes precursors (Cirone et al., 2008, 2007). DC
function is also modulated by HIV-1, and the interaction of DCs and
HIV-1 plays a critical role in viral pathogenesis (Wu, 2008; Wu and
KewalRamani, 2006).
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between HIV-1 and KSHV in regulating viral replication and
human carcinogenesis, while limited investigation has focused
on the potential effects of KSHV on DC–HIV-1 interactions. Here,
we report that KSHV stimulation could promote maturation of
monocyte-derived DCs (MDDCs), and KSHV-stimulated MDDCs
could capture more HIV-1 particles and efﬁciently transfer these
infectious viruses to CD4þ T cell line Hut/CCR5. Our results reveal
the novel modulation of KSHV and DC-mediated HIV-1 dissemi-
nation. Understanding the effects of co-operating pathogens on
DC–HIV-1 interaction could facilitate the elucidation of HIV/AIDS
pathogenesis.Results
Induction of infectious KSHV from latently infected endothelial cells
iSLK.219 cell displays tight control of KSHV latency and is
efﬁciently inducible by doxycycline. GFP is constitutively
expressed in these cells and RFP is expressed during lytic
replication, as described previously (Myoung and Ganem, 2011),
Doxycycline induces iSLK.219 cells for lytic replication to gener-
ate large quantities of infectious rKSHV.219 viruses (Fig. 1A).
Infection of HEK293T cells was quantiﬁed (Fig. 1B) by detecting
GFP expression with ﬂow cytometry, and a dose-dependent viraliSLK.219 cells
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Fig. 1. Generation of infectious recombinant KSHV stock. (A) RTA-inducible SLK cell
doxycycline for 48 h. All cells remained GFPþ RFP when no induction stimulus was pro
suggesting that lytic replication was highly induced. ((B) and (C)) 293T cells were infe
were monitored by ﬂow cytometry. rKSHV was killed by UV irradiation for 4 h. Percenta
LANA genes was quantiﬁed and normalized with b-actin. KSHV-w/o RT, means these RN
of one representative experiment out of three are shown. nnnPo0.001, were considereinfection was observed. These infectious rKSHV.219 viruses were
killed by ultraviolet (UV) irradiation for 4 h (Fig. 1B). The replica-
tion of rKSHV.219 in HEK293T cells was conﬁrmed by detecting
the mRNA production of rKSHV ORF8 and LANA genes. ORF8 and
LANA represent lytic and latent gene products of KSHV, respec-
tively. Viral gene expression could be detected for high expression
in KSHV-infected HEK293T cells at the indicated time of
post-infection, but no viral gene expression was observe when
UV-killed KSHV for infection (Fig. 1C). Together, these data
demonstrate infectious recombinant KSHV viruses can be induced
from latently infected iSLK.219 cells.Stimulation of rKSHV promotes maturation of MDDCs
We and others have previously proved that AIDS-associated
pathogens can promote maturation of DCs (Diou et al., 2010a,
2010b; Qin et al., 2011, 2012; Reuter et al., 2010; Vachot et al.,
2008). To determine the potential effects on MDDC maturation by
KSHV, immature MDDCs were co-cultured with different amounts
of rKSHV for 48 h. Cell phenotype was monitored by immuno-
staining of surface markers. The co-stimulatory molecules of
CD83 and CD86 and HLA-DR showed enhanced expression
(Fig. 2A), indicating maturation of MDDCs. Lipopolysaccharide
(LPS) was used as the control for inducing MDDC maturation
(Wang et al., 2007). When rKSHV was killed by UV radiation, the
inactivated rKSHV could still promote expression of CD83, CD86MOI=0.25 MOI=0.5MockInfection
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Fig. 2. rKSHV stimulation promotes maturation of DCs. rKSHV was used to stimulate MDDCs for 48 h. (A) MDDC phenotype was monitored by measuring the expression
level of CD83, CD86, and HLA-DR on the cell surface with ﬂow cytometry. (B) Potential rKSHV infection of MDDCs was assessed by detecting the relative mRNA production
of rKSHV ORF8 and LANA gene, at the indicated time of post-infection. (C) Cell viability after rKSHV stimulation was monitored by using PI exclusion assay and measured
by ﬂow cytometry. Positive percentage and mean ﬂuorescence intensity (MFI) are shown in (A) and (C). MFI is calculated with percentage timing ﬂuorescence value.
Results of one representative experiment out of four are shown. Dpi: days post-infection.
W. Liu et al. / Virology 440 (2013) 150–159152and HLA-DR, suggesting that viral binding can induce cell matura-
tion, and the apparent viral gene expression is dispensable
(Fig. 2A). To conﬁrm this point, rKSHV replication in MDDCswas measured by detecting the mRNA production of rKSHV ORF8
and LANA genes. There was no or slight enhancement of mRNA
production at 2 or 4 days post-viral inoculation (Fig. 2B),
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attributed to intracellular replication of viruses. Cell viability
after 48 h viral inoculation was monitored by PI exclusion assay.
The lower amount of rKSHV (MOI 0.1 or 0.5) that was used above
for DC stimulation caused o1.5% cell death, whereas the higher
amount of virus (MOI 1) led to about 20% cell death. H2O2 (3%)
was used as a control for necrosis induction (Fig. 2C). Taken
together, these data demonstrated that the stimulation of rKSHV
promotes maturation of MDDCs, and viral gene expression may
be dispensable for MDDCs maturation.
rKSHV stimulation impairs DC-induced proliferation of CD4þ T cells
KSHV has been reported for antagonizing host antiviral
responses by suppresses activation of interferon regulatory factor,
contributing to immune-evasion (Liang et al., 2012; Zhu et al.,
2002). To investigate the potential effect of KSHV on DC-induced
T-cell proliferation, MDDCs were pulsed with rKSHV or control
medium for 48 h. After washing, MDDCs were co-cultured with
CFSE-labeled, allogeneic resting CD4þ T cells for an additional
6 days (Fig. 3A), and T-cell proliferation was monitored by
detection of CFSE intensity. rKSHV-activated DCs impaired
CD4þ T-cell proliferation (Fig. 3B). KSHV-inoculated MDDCs were
investigated for viral constitutively expressed-GFP to make sure
no GFP color background has been contaminated in CFSE detec-
tion (Fig. 3C).
rKSHV-stimulated MDDCs enhance HIV-1 endocytosis in a DC-SIGN -
independent manner but impair HIV-1 infection
Mature DCs take up HIV-1 particles, which can be sequestered
intracellularly for escaping proteolysis and transferred to CD4þ
T cells (Wang et al., 2007; Wu and KewalRamani, 2006). To
determine whether rKSHV-stimulated MDDCs could also take
up more HIV-1 particles, the non-infectious VLP, HIV-gag-GFP/
JFRL, was used, and VLP binding and internalization were tested.
At 4 1C, more VLPs were bound to rKSHV-stimulated MDDCs, and
GFP-positive cells increased from 5.8% to 7.2–10.9%, as detected
by ﬂow cytometry (Fig. 4A). At 37 1C, rKSHV-stimulated MDDCs
took up many more VLPs compared with medium-treated
MDDCs, and the GFP-positive cells increased from 16.3% to
464% (Fig. 4A). Notably, most of the VLPs could not be removed
with trypsin digestion from the cell surface of rKSHV-stimulated
MDDCs, suggesting viral internalization. Immature-DC-mediated
viral uptake mainly depends on viral surface binding (Wang et al.,
2007), so as expected, VLPs could be removed with trypsin
digestion from the surface of immature MDDCs (Fig. 4A).
Similarly, confocal microscopy showed that more VLPs were
internalized in rKSHV-stimulated MDDCs, however, medium-
treated MDDCs bound VLPs mainly on the cell surface (Fig. 4B).
Next, we were interested in whether the enhanced HIV-1
binding and endocytosis could promote HIV-1 infection. Different
amounts of infectious rKSHV were used to stimulate MDDCs for
48 h, and MDDCs were inoculated with single-cycle, luciferase
reporter HIV-Luc/JRFL (CCR5-tropic), and HIV-1 infection was
measured by detecting the luciferase activity in cell lysates 5 days
post-infection. HIV-1 infection in rKSHV-stimulated MDDCs was
impaired (Fig. 4C).
The molecule of DC-SIGN has been proved previously for
mediating HIV-1 binding and endocytosis (Geijtenbeek et al.,
2000; Wang et al., 2007; Wu and KewalRamani, 2006), in order
to determine whether DC-SIGN mediates the enhanced HIV-1
uptake on KSHV-stimulated MDDCs, anti-DC-SIGN speciﬁc anti-
bodies was used for prior-blocking of MDDCs before HIV-1/VLP
addition. The prior-blocking with anti-DC-SIGN antibodies did not
diminish HIV-1/VLP uptake in KSHV-treated MDDCs (Fig. 5A),suggesting a DC-SIGN-independent manner has been adopted.
Immature MDDCs (untreated control) bind HIV-1 mainly through
surface-expressed DC-SIGN (Wang et al., 2007; Wu and
KewalRamani, 2006), which can be easily blocked by prior-
treatment with anti-DC-SIGN antibodies (Fig. 5A). Moreover,
KSHV-stimulation diminished DC-SIGN expression on MDDCs, as
detected with ﬂow cytometry (Fig. 5B).
Taken together, these data demonstrate that rKSHV-
stimulated MDDCs enhance HIV-1 endocytosis in a DC-SIGN -
independent manner but impair HIV-1 infection.
rKSHV-activated MDDCs increase ICAM-1 expression and facilitate
DC-mediated HIV-1 transmission to T cells
DCs have been previously shown to be hijacked by HIV-1 for
mediating viral transmission to CD4þ T cells for robust replica-
tion (McDonald et al., 2003; Wang et al., 2007, 2009; Wu, 2008;
Wu and KewalRamani, 2006). To investigate whether rKSHV-
activated MDDCs can promote HIV-1 transfer to T cells, MDDCs
stimulated with different amounts of rKSHV or medium were
loaded with HIV-luc/JRFL, and then co-cultured with Hut/CCR5
cells, the CD4þ T cell line (Fig. 6A). Viral transfer was measured
by testing viral infection in T cells. rKSHV-activated MDDCs
enhanced HIV-1 transfer to T cells (Fig. 6B).
DC and T cells form the virological synapses for providing the
most efﬁcient route for HIV-1 transfer (McDonald et al., 2003;
Wang et al., 2007), and ICAM-1-lymphocyte function-associated
antigen (LFA)-1 interaction is involved in the formation of DC-T-
cell conjunction (Wang et al., 2009). To investigate whether
rKSHV-activated MDDCs could increase ICAM-1 expression and
promote HIV-1 transfer to T cells, ICAM-1 was immunostained
and detected by ﬂow cytometry. Stimulation with rKSHV
enhanced ICAM-1 expression on MDDCs by 1.4–1.7-fold, regard-
less of whether infectious or inactivated rKSHV was used (Fig. 6C).
The formation of virological synapses was visualized by confocal
microscopy, and Hut/CCR5 T cells were used as target cells
(Fig. 6D). More viral particles were efﬁciently recruited at
rKSHV-activated MDDC-T cell contact sites to form the virological
synapses.
Taken together, these data demonstrate that rKSHV-
stimulated MDDCs enhance ICAM-1 expression and recruit more
HIV-1 particles to the virological synapses for enhanced viral
transmission.Discussion
DCs are pivotal immune cells for regulating host immunity
(Wu, 2008; Wu and KewalRamani, 2006). The multiple functions
of DCs have been modulated by both KSHV and HIV-1 for regulating
viral dissemination and immunoevasion. The susceptibility of DCs
for both KSHV and HIV-1 infection provides a converging point for
investigating the interaction between KSHV and HIV-1. The abun-
dant expression of DC-SIGN offers KSHV binding and infection of
monocytes-derived DCs and macrophages (Rappocciolo et al., 2006).
KSHV infection can decrease DC-SIGN expression (Rappocciolo et al.,
2006), and inhibition of its transcription has been reported in DCs
infected by HHV-6 (Niiya et al., 2004). We also found that inocula-
tion of UV-inactivated KSHV compromised, but not completely
abolished, downregulation of DC-SIGN, indicating that viral binding
and replication might both modulate DC-SIGN expression (data not
shown).
KSHV infection promotes maturation of DCs (Rappocciolo
et al., 2006), as assessed by upregulation of co-stimulatory
molecules CD80 and CD83. We found that KSHV binding also
promoted maturation of DCs, although the viral components
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infection has been shown to alter chemokine receptor CCR6
expression on immature DCs, inhibit the migratory behavior of
both immature and mature DCs, and induce cytoskeleton reorga-
nization (Cirone et al., 2012). KSHV-treated DCs show impaired
antigen presentation and allostimulatory activity, and alter the
cytokine production proﬁles (Cirone et al., 2008; Della Bella et al.,
2006; Hensler et al., 2009; Rappocciolo et al., 2006). We con-
ﬁrmed the defective capacity of KSHV-stimulated DCs for indu-
cing proliferation of resting CD4þ T cells. Our data also suggest
that robust infection of KSHV may not be necessarily required for
DC functional impairment. In contrast, DC maturation induced
by KSHV-encoded components has been exploited for improving
the efﬁcacy of vaccine vectors (Rowe et al., 2009). The gene
encoding KSHV vFLIP (viral encoded, Fas-associated death
domain-like IL-1b-converting enzyme inhibitory protein) has
been incorporated into a lentivector (Rowe et al., 2009).Expression of this oncoprotein activates nuclear factor-kB in
mouse bone-marrow-derived DCs and promotes maturation of
DCs; the co-stimulatory markers CD80, CD86, CD40, and ICAM-1
are upregulated; and tumor necrosis factor a and IL-12 are
secreted. The vFLIP-expressing lentivector increases CD8þ T-cell
response, correlated with improved tumor-free survival in a
tumor therapy model, and reduces the parasite load when mice
are challenged with Leishmania donovani.
The alteration of DC function induced by KSHV will surely
provide more opportunities for HIV-1 hijacking and further
deterioration of the immune system. We have shown previously
that AIDS-associated fungal pathogens enhance maturation of
DCs and promote DC ability to mediate HIV-1 transmission(Qin
et al., 2011, 2012). Here, we demonstrated that KSHV-stimulated
DCs also could capture more HIV-1 particles and enhanced HIV-1
transfer to CD4þ T cells for robust infection. The increased
expression of ICAM-1 strengthens the DC-T cell interaction, which
Stimulated-DCs for
co-culture with T cells 
H
IV
-1
 in
fe
ct
io
n
(lu
ci
fe
ra
se
 a
ct
iv
ity
, c
ps
 ) 
0
100000
200000
300000
400000
500000
600000
700000
DC
alone
untreated KSHV
/0. 1
*
**
KSHV
/0. 5
DC+ T cells DC/KSHV+ T cells
HIV-1, β-actin, DAPI, DIC  
T
DC
DC
T
ICAM-I expression (log fluorescence)
SS
C MFI:11988MFI:6855 MFI:11888 MFI:9621
Untreated MOI=0.1 MOI=0.5 MOI=0.5/ UV
DC-mediated HIV-1 trans-infection
K
SH
V-
tr
ea
te
d
M
D
D
C
s HIV-1
CD4+ T cells
Fig. 6. rKSHV-stimulated MDDCs increase surface expression of ICAM-1 and facilitate MDDC-mediated HIV-1 transmission. (A) Schematic illustration for DCs
treatment by KSHV and HIV-1 trans-infection mediated by DCs. (B) Enhanced HIV-1 transmission mediated by rKSHV-stimulated MDDCs. HIV-luc/JFRL-loaded, rKSHV- or
medium-stimulated MDDCs were co-cultured with Hut/CCR5 for 3 days, and HIV-1 transfer was detected by measuring viral infection. DC alone, means that HIV-loaded
MDDC are not co-cultured with Hut/CCR5 T cells. Data are mean7SD. Results of one representative experiment out of four are shown. nPo0.05 and nnPo0.01 were
considered signiﬁcant difference in Student’s t test. (C) Increased ICAM-1 expression on rKSHV-stimulated MDDCs. MDDCs were treated with rKSHV, and the surface level
of ICAM-1 was detected by ﬂow cytometry. The MFI values are shown, MFI is calculated with percentage timing ﬂuorescence value. (D) Enhanced viral concentration on
the contact sites between MDDCs and T cells. MDDCs were treated with rKSHV (MOI 0.5) for 48 h, and HIV-1 VLPs (4 ng p24gag) were added for 2 h incubation, and after
washing Hut/CCR5 cells were added as target cells for an additional 30 min co-culture. Cells were ﬁxed for immunostaining or labeling and observed by confocal
microscopy. b-Actin was displayed in red, and nuclei were stained blue with DAPI. DIC, differential interference contrast. Scale bars, 5 mm.
W. Liu et al. / Virology 440 (2013) 150–159 157is a key route for HIV-1 transfer between cells. DCs are not the
only hijacked target for KSHV to enhance HIV-1 replication and
viral burden. Several KSHV proteins, for example, LANA, the
immediate-early protein KIE-2, the oncoprotein vFLIP K13, and
ORF50 (Rta), have been reported to lead to activation of HIV-1 LTR
to enhance HIV-1 transcription in CD4þ T cells (Caselli et al.,
2003a, 2003b, 2001; Sun et al., 2005). KSHV infection induces
HIV-1 reactivation in chronically infected cell lines and in PBMCs
from asymptomatic patients (Caselli et al., 2005). In contrast, HIV-
1-induced immunosuppresion plays an important role in the
pathogenesis of KSHV-associated cancer. HIV-1 Tat proteinactivates lytic cycle replication of KSHV (Aoki and Tosato, 2004;
Merat et al., 2002; Varthakavi et al., 2002; Zeng et al., 2007), and
induces KS-like lesions in nude mice and angiogenesis. HIV-1 Tat
protein can increase KSHV vGPCR (KSHV-encoded G-protein-
coupled receptor) signaling, resulting in the KSHV lytic biological
cycle and accelerated tumorigenesis (Pati et al., 2003).
Besides KSHV, DCs also can be targeted by other AIDS-
associated opportunistic pathogens to cause deterioration of the
host immune response and promote HIV-1 dissemination (Diou
et al., 2010a, 2010b; Qin et al., 2011, 2012; Reuter et al., 2010;
Vachot et al., 2008). Give the pivotal role of DCs in HIV-1
W. Liu et al. / Virology 440 (2013) 150–159158pathogenesis, understanding the effects of these co-pathogens on
DC–HIV-1 interaction could help to elucidate HIV-1 pathogenesis
and the search for novel strategies to combat AIDS.Materials and methods
Cells
Human peripheral blood mononuclear cells (PBMCs) from
healthy donors were provided by the Blood Center of Shanghai,
China. CD14þ monocytes and resting CD4þ T cells were puriﬁed
from PBMCs using magnetic beads (BD Biosciences) as described
previously (Shen et al., 2012). CD14þ monocytes were cultured
with granulocyte–macrophage colony-stimulating factor and IL-4
for 6 days to generate immature DCs. The human embryonic
kidney cell lines HEK293T and the CD4þ T-cell line Hut/CCR5
were kind gifts from Dr. Li Wu (the Ohio State University, USA)
and Dr. Vineet Kewal Ramani (National Cancer Institute,
NIH, USA).
The KSHV latently infected SLK endothelial cells, iSLK.219,
have been described previously (Myoung and Ganem, 2011),
iSLK.219 cells were derived from SLK endothelial cells that were
ﬁrst engineered with a doxycycline-inducible RTA transgene and
then latently infected with a recombinant KSHV.219 virus. This
cell line was donated by Dr. Myoung J (Howard Hughes Medical
Institute, University of California, San Francisco, CA, USA ).
iSLK.219 cells were maintained in Dulbecco’s Modiﬁed Eagle’s
Medium supplemented with hygromycin (100 mg/ml) (Invitro-
gen), puromycin (4 mg/ml) (Invitrogen) and G418 (100 mg/ml)
(Sigma), 10% fetal bovine serum, and penicillin–streptomycin.
Flow cytometry
Cells were stained with speciﬁc monoclonal antibodies (McAbs) or
isotype-matched IgG controls. McAbs against the following human
molecules were used for staining (clone numbers and resources are
given in parentheses), APC-Alexa Fluor750 CD11c (B-ly6; BD Phar-
mingen), Phycoerythrin (PE)–ICAM-1 (CD54) (HA58; e-Bioscience),
PE-CD83 (HB15e; eBioscience), PE-CD86 (IT2.2; eBioscience), PE-
DC-SIGN (DC-speciﬁc ICAM-3-grabbing nonintegrin) (eBh209;
eBioscience), and APC-cy7-HLA-DR (LN3; eBioscience). Stained cells
were detected with an LSRII ﬂow cytometer (BD Biosciences Phar-
mingen) and analyzed with FlowJo 7.6.1 software (TreeStar Inc.).
rKSHV.219 generation and infection
Inducible iSLK.219 cells were generated as described pre-
viously (Myoung and Ganem, 2011). iSLK.219 cells contained
recombinant KSHV.219 (rKSHV.219) and expressed RTA (replica-
tion and transcription activator) under control of a doxycycline-
responsive promoter (tetracycline-responsive element). iSLK.219
cells were induced with 0.2 mg/ml doxycycline. Thirty-six hours
post-induction, the mediumwas refreshed for an additional 3 days
culture, and the supernatants containing rKSHV were harvested,
ﬁltered, aliquoted and stored at 80 1C. KSHV was inactivated for
4 h with ultraviolet (UV) irradiation with power of 40 W.
MDDCs or HEK293T cells were inoculated with varied amounts
of rKSHV for the indicated time. Viral replication was determined by
subsequent enumeration of GFP-expressing cells with ﬂow cytome-
try, or by quantiﬁcation of mRNA production of KSHV open reading
frame (ORF)8 and ORF73 (latency-associated nuclear antigen; LANA)
with RT-PCR and normalization with b-actin. Viral titration was
determined on HEK293T cells based on GFPþ cell enumeration by
ﬂuorescence microscopy. The following primers were used: ORF8-F:
50-TCGCCGCACCAATACCATA, ORF8-R: 50-CCTGCGATCTACGTCGGG;ORF73 (LANA)-F: 50-GAAGTGGATTACCCTGT TGTTAGC, and ORF73
(LANA)-R: 50-TTGGATCTCGTCTTCCATCC; b-actin-F: 50-GGGAAATCG-
TGCGTGACAT-30, b-actin-R: 50-GTCAGGCAGCTCGTAGCTCT T-30.
MDDC viability was evaluated with a dead cell apoptosis kit with
Annexin V Alexa Fluor 488 and propidium iodide (PI) (Invitrogen).
Stained cells were detected with an LSRII ﬂow cytometer and
analyzed with FlowJo 7.6.1 software.
HIV-1 or virus-like particle (VLP) stocks
Pseudotyped single-cycle HIV-1 stocks were generated by
using calcium-phosphate-mediated co-transfection of HEK293T
cells with the plasmid pLAI-Denv-Luc and expression plasmid of
JRFL (R5-tropic) envelope glycoprotein, as described previously
(Shen et al., 2012). The VLP, HIV-1-Gag-GFP/JRFL, was generated
by co-transfection of HEK293T cells with a plasmid encoding HIV-
Gag-GFP and with JRFL plasmid. The plasmids were kind gifts
from Dr. Li Wu (the Ohio State University, USA). Virus stocks and
VLPs were quantiﬁed using p24gag capture ELISA and stored at
80 1C.
HIV-1 binding and internalization
HIV-1 binding and internalization were quantiﬁed by ﬂow
cytometry using the VLP HIV-Gag-GFP/JRFL. KSHV-stimulated
MDDCs were incubated with VLPs (4 ng p24gag) for 2 h at 4 or
37 1C, and washed. Some samples were prior-blocked with anti-
DC-SIGN speciﬁc antibodies (10 mg/ml) (Clone 120507; Abcam)
for 30 min. Some cells were treated with 0.25% trypsin (without
EDTA) for 5 min at 37 1C to remove surface-bound VLPs. The
amounts of VLP associated with MDDCs were quantiﬁed by ﬂow
cytometry.
HIV transmission assays
The luciferase reporter system was adopted for assay of HIV-1
transmission as previously described (Qin et al., 2011, 2012).
MDDCs were pulsed with 5 ng p24gag amounts of pseudotyped
HIV-luc/JRFL for 2 h, and cells were washed for culture or
co-culture with CD4þ T cell line, Hut/CCR5 cells. Cells were
harvested at 3 days post-infection, and the cell lysates were
measured for luciferase activity with a commercially available
kit (Promega).
Confocal microscopy
The formation of virological synapses was observed by con-
focal microscopy. MDDCs were pulsed with HIV-1 VLPs (4 ng
p24gag of HIV-Gag-GFP/JRFL) and co-cultured with Hut/CCR5 for
30 min. Cells were seeded on the poly-L-lysine-coated microscope
slides and ﬁxed with 4% paraformaldehyde (Sigma-Aldrich) for
1 h at 4 1C. Cells were immunostained with anti-b-actin anti-
bodies (AC-15; Sigma), followed by staining with Alexa-Fluor-
555-labeled goat anti-mouse IgG (Invitrogen). Nuclei were
stained with DAPI. Slides were mounted with Fluorescent Mount-
ing Medium (Dako) and observed using a laser scanning confocal
microscope (Leica SP5).
T-cells proliferation assay
KSHV-stimulated MDDCs were used to co-culture with CFSE
(5-carboxyﬂuorescein diacetate succinmidyl ester) (Invitrogen)-
labeled allogeneic resting CD4þ T cells for 6 days at the ratio of
1:10 (MDDC:T). The T cells were gated based on the CFSE-positive
population, and proliferation was analyzed using a ﬂow cyto-
meter by detecting CSFE intensity.
W. Liu et al. / Virology 440 (2013) 150–159 159Statistical analysis
Statistical analysis was performed using paired t test with the
SigmaStat program.Acknowledgments
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